NovaBridge Biosciences American Depositary Shares (NBP)

About NBP

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

30

Website

www.novabridge.com/

Fundamentals

1-day range

$1.79$1.9

Market cap

$185.76M

P/E (trailing)

—

P/E (forward)

-1.74

EPS (trailing)

$-0.19

Dividend yield

—

Beta

1.56

Avg. volume

470.9K

Forecasts

4 analyst ratings

NovaBridge Biosciences American Depositary Shares Competitors

Chosen by industry and closest market cap.

• NBP

  NovaBridge Biosciences American Depositary Shares

  $1.85

  ▼ 2.38%
  Market cap $185.76MP/E —
  $1.46$6.79
• IMUX

  Immunic Inc. Common Stock

  $15.4

  ▼ 5.52%
  Market cap $192.06MP/E —
  $5.06$17.43
• GLSI

  Greenwich LifeSciences Inc. Common Stock

  $15.67

  ▼ 16.34%
  Market cap $198.74MP/E —
  $7.78$34.1
• EVO

  Evotec SE American Depositary Shares

  $1.91

  ▼ 2.80%
  Market cap $172.06MP/E —
  $3.18$7.3
• KROS

  Keros Therapeutics Inc. Common Stock

  $11.05

  ▼ 1.60%
  Market cap $200.10MP/E —
  $9.69$22.55
• ARCT

  Arcturus Therapeutics Holdings Inc. Common Stock

  $15.19

  ▼ 6.06%
  Market cap $170.54MP/E —
  $5.5$24.17
• TNXP

  Tonix Pharmaceuticals Holding Corp. Common Stock

  $13.59

  ▲ 0.18%
  Market cap $170.01MP/E —
  $9.4$34.04

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target
  benzinga · 8/20/2026
• HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target
  Benzinga · 8/20/2026
• NovaBridge Biosciences (NBP) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/20/2026
• NovaBridge Biosciences H1 EPS $(0.33) Misses $(0.14) Estimate
  Benzinga · 8/20/2026

• Robert A. Lenz · August 22, 2026 · Option Exercise

  7.5K
• Robert A. Lenz · August 22, 2026 · Option Exercise

  17.2K
• Mark Arnold Hagler · July 8, 2026 · Grant

  949.0K
• Lin Liwei Lorraine · July 8, 2026 · Grant

  254.8K
• Gupta Srishti · July 6, 2026 · Grant

  3.00M
• Cong Claire Xu · July 6, 2026 · Sale

  4.5K @ $0.89
• Cong Claire Xu · July 4, 2026 · Option Exercise

  5.4K
• Cong Claire Xu · July 4, 2026 · Option Exercise

  12.4K
• Sean Wuxiong Cao · June 22, 2026 · Grant

  181.3K
• Sean Wuxiong Cao · June 22, 2026 · Grant

  181.3K
• Phillip Andrew Dennis · June 18, 2026 · Sale

  8.5K @ $0.66
• Phillip Andrew Dennis · June 17, 2026 · Option Exercise

  10.3K
• Phillip Andrew Dennis · June 17, 2026 · Option Exercise

  23.7K
• Cong Claire Xu · June 1, 2026 · Sale

  3.5K @ $3.94
• Cong Claire Xu · May 30, 2026 · Option Exercise

  4.1K

Institutional Ownership

March 31, 2026

Total shares held

29.28M

Total value held

$71.73M

Institutional holders

48